Artificial intelligence could have profound implications for the field of oncology, concluded panelists speaking to journalist and moderator Katie Couric at the Constellation Forum 2023 at Northwell Health last week.
Dr. Richard Barakat, physician in chief and executive director of cancer services and research division at Northwell Health, noted that using AI in imaging will help radiologists and...
Paige, a digital pathology diagnostics company, has received De Novo marketing authorization from the Food and Drug Administration for its artificial intelligence software that helps detect prostate cancer.
The Paige Prostate software analyzes digitized biopsy slides and identifies areas that could be cancerous for the pathologist to review further.
“The approval is a landmark achievement in the...
Cedar, the maker of an intelligent patient billing and engagement platform, announced today a $200 million Series D round of funding headed by Tiger Global Management, with participation from prior backers including Andreessen Horowitz (a16z), Thrive Capital and Concord Health Partners. This brings the company's total fundraising haul to $350 million, it said, and its valuation to $3.2 billion....
AI-enabled diagnostic and treatment platform Paige (formerly Paige.AI) has announced a $100 million Series C round led by Casdin Capital and Johnson & Johnson Innovation. The startup's prior backers and other unnamed funds also took part in the raise.
Paige uses computational and digital pathology to help oncologists and pathologists make decisions faster, more accurately and at a lower...
CUMBRIA SEXUAL HEALTH SERVICE DIGITISES BOOKINGS
Cumbria Sexual Health Service (CSHS) will offer its patients the ability to book appointments and order STI self-testing kits online.
The initiative is expected to become available to patients in the New Year, while plans form part of an project designed to improve access and reduce pressure on clinic staff.
Once live, patients will register on...
Paige, a computational pathology platform, announced today an additional $15 million from Goldman Sachs Merchant Banking Division, bringing the total capital from the firm to $20 million.
Healthcare Venture Partners also contributed an additional $5 million on top of its previous $10 million investment.
With this funding, the previously announced Series B financing round increased to $70 million...
Computational pathology platform Paige scored an additional $5 million from Goldman Sachs this week, closing its Series B funding at $50 million – exactly double its Series A funding amount.
As part of the news, Paige announced that David Castelblanco, managing director at Goldman Sachs, will be joining its board of directors.
In December, the company announced its initial $45 million round that...
This morning the AI-enabled diagnostic and treatment platform Paige, formerly called Paige.AI, announced a $45 million Series B funding round. The latest raise was led by Healthcare Venture Partners with participation from Breyer Capital, Kenan Turnacioglu and other funders.
Today the company has $70 million in investments. This latest round comes roughly two years after the company closed a $25...
